Scientometric analysis and historical review of diabetic encephalopathy research: Trends and hotspots (2004-2023)

Figure 1 Flow chart of the study of diabetic encephalopathy.

Figure 2 Number of publications by year and gerontology.

Figure 3 Country/region analysis. Number of publications by country or region, and cooperative relationships among countries or regions.

Figure 4 Journal analysis. A: Articles related to diabetic encephalopathy published in a different journal; B: Research on mutual citations of journals.

Figure 5 Literature and cited references analysis. A: Literature citation network; B: Reference citation network.

Figure 6 Keyword analysis. A: Keyword timeline view; B: Keyword co-occurrence network; C: Top 25 keywords with the strongest citation bursts; D: Population distribution.

Figure 7 Manual analysis results. A: Induction factor; B: Disease type; C: Disease mechanism; D: Disease targets; E: Disease therapy; F: Disease drugs; G: Traditional Chinese medicine; H: Animal model.

Figure 8 Pathogenesis of diabetic encephalopathy. PI3K: Phosphatidylinositol 3-kinase; AMPK: Adenosine monophosphate-activated protein kinase; mTOR: Mechanistic target of rapamycin; Bcl-2: B cell leukemia/lymphoma 2; Bax: B cell leukemia/lymphoma 2-associated X; NLRP3: NLR family pyrin domain containing 3; IL: Interleukin; TNF-α: Tumor necrosis factor α.